Varian, a Siemens Healthineers company, has received 510(k) clearance from the U.S. FDA for the TrueBeam and Edge radiotherapy systems featuring the HyperSight imaging solution.
At this year’s ECR in Vienna, Philips introduced the Philips CT 5300 system equipped with advanced AI capabilities designed to be used for diagnosis, interventional procedures and screening. This flexible CT system in reases diagnostic confidence, streamlines workflow efficiency, and maximizes system up-time, helping to improve patient outcomes and department productivity.
Following the recent CE approval of the Solia S lead (1) for Left Bundle Branch Area Pacing (LBBAP), BIOTRONIK now provides the world’s first and only complete CSP system, fully CE-approved for LBBAP. (2)
Philips’ new X11-4t Mini 3D TEE ultrasound transducer has received US FDA approval.
Medtronic has received the CE Mark for its Micra AV2 and Micra VR2 miniature, leadless pacemakers.
Medtronic has received CE Mark approval for their MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM) requiring no fingersticks or overtape. Simplera Sync features an improved user experience with a simple, two-step insertion process and is half the size of previous Medtronic sensors.
Stryker has expanded its Gamma4 Hip Fracture Nailing System, with the addition of an intermediate nail, the RC Lag Screw, and an anti-rotation clip with sleeve components. Since its launch in August of 2022, the Gamma4 System has been used in over 19,000 cases across more than 850 facilities, solidifying its position as a leading […]
Innovia Medical showcased their DTR Medical Cervical Rotating Biopsy Punch at this year’s Arab Health Exhibition in Dubai. The device is designed for obtaining cervical biopsies during gynaecological procedures. The device’s single-use eliminates cross-contamination.
Marking a pivotal point in a nine-year journey of innovation, OTSAW, a leader in Singapore’s robotics landscape, introduces Camello+, an autonomous mobile robot (AMR) poised to revolutionize various industries, including healthcare.
Medtronic has received US FDA approval for the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF). This is the first PFA technology to receive FDA approval and follows the European CE Mark approval for the PulseSelect PFA system in November.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.